Pharmaceutisch Weekblad

, Volume 14, Issue 1, pp 1–8 | Cite as

Drug use in non-hospitalized children

  • Emilio J. Sanz


The knowledge of the characteristics of the use of drugs in non-hospitalized children is of paramount importance since clinical trials are seldom (and sometimes should not be) performed in such patients. The source of drug prescriptions varies a lot: ‘self-administration’ through parents accounts for as much as formal physician's orders or pharmacist's counselling. Data can be collected through the whole drug chain: drug prescription-drug dispensing-drug attainment-drug consumption. Both qualitative and quantitative data are to be collected in order to draw a complete picture of drug use in non-hospitalized children. Longitudinal collection methods, as well as time-point or cross-sectional studies can be carried out. The particular role of each of these methods of performing a drug utilization study in children are analysed and discussed.


Attitude to health Child Data collection Drug utilization Drugs, non-prescription Parents Patient education Pharmaco-epidemiology Side effects 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Catford JC. Quality of prescribing for children in general practice. Br Med J 1980;14:1435–7.Google Scholar
  2. 2.
    Kennedy DL, Forbes MB. Drug therapy for ambulatory pediatric patients in 1979. Pediatrics 1982;70:26–9.Google Scholar
  3. 3.
    Duque J. Estudio de la prescripción materna de medicamentos en el niño — automedicación materna transferida [Mothers' prescription of drugs to their children] [dissertation]. La Laguna: Univ of La Laguna, 1987.Google Scholar
  4. 4.
    Rasmusssen F, Smedby B. Physician visits and prescribed drugs among young children and their mothers. Scand J Prim Health Care 1987;5:225–31.Google Scholar
  5. 5.
    Sanz E, Boada J. Adverse drug reactions in paediatric outpatients. Int J Clin Pharm Res 1987;7:169–72.Google Scholar
  6. 6.
    Rylance GW, Woods CG, Cullen RE, Rylance ME. Use of drugs by children. BMJ 1988;297:445–7.Google Scholar
  7. 7.
    Sanz E, Boada J. Drug utilization by children in Tenerife Island. Eur J Clin Pharmacol 1988;34:495–9.Google Scholar
  8. 8.
    Sanz E, Bergman U, Dahlström M. Pediatric drug prescribing. A comparison of Tenerife (Canary Islands, Spain) and Sweden. Eur J Clin Pharmacol 1989;37:65–8.Google Scholar
  9. 9.
    Hemminki E. Review of literature on the factors affecting drug prescribing. Soc Sci Med 1975;9:111–5.Google Scholar
  10. 10.
    World Health Organization. Drugs for infants and children. Report of the tenth European symposium on clinical pharmacology evaluation in drug control, Schlangenbad, October 1981. EURO Report and Studies 66. Copenhagen: WHO Regional Office for Europe, 1982.Google Scholar
  11. 11.
    Iannotti RJ, Bush PJ. The development of autonomy in children's health behaviors. In: Sussman EJ, Feagens LV, Ray W, eds. Emotion, cognition, health and development in children and adolescents: a two-way street. Hillsdale: Lawrence Erlbaum. In press.Google Scholar
  12. 12.
    Bush PJ, Iannotti RJ. Origins and stability of children's health beliefs relative to medicine use. Soc Sci Med 1988;27:345–52.Google Scholar
  13. 13.
    Bush PJ, Iannotti RJ. A children's health belief model. Med Care 1990;28:69–86.Google Scholar
  14. 14.
    Bush PJ, Hardon AP. Towards rational medicine use: is there a role for children? Soc Sci Med 1990;31:1043–50.Google Scholar
  15. 15.
    Bush PJ, Iannotti RJ, Davidson FR. A longitudinal study of children and medicines. In: Breimer DD, Speiser P, eds. Topics in pharmaceutical sciences. Amsterdam: Elsevier Science Publishers, 1985:391–403.Google Scholar
  16. 16.
    Smith MC. Social barriers to rational drug therapy. Am J Hosp Pharm 1972;29:121–7.Google Scholar
  17. 17.
    Fulton WW. Why do doctors prescribe psychotropic drugs? J R Coll Gen Pract 1973;23:22–4.Google Scholar
  18. 18.
    Howie JG, Bigg AR. Family trends in psychotropic and antibiotic prescribing in general practice. Br Med J 1980;280:836–8.Google Scholar
  19. 19.
    Ames J, Hayden G, Campbell R, Lohr J. Parents' conception of their use of over-the-counter medicines. Clin Pediatr 1982;21:298–301.Google Scholar
  20. 20.
    Juergens JP, Smith MC, Sharpe TR. Mothers' anxiety and medication use in rural families on welfare. Am J Hosp Pharm 1983;40:103–6.Google Scholar
  21. 21.
    Bryan C, Bryan J. Perception of disease and compliance with pediatric medical regimens and the effects on assessment of treatment in ambulatory disease. In: Couveia A, Tognoni G, Van der Kleijn E, eds. Clinical pharmacy and clinical pharmacology. Amsterdam: Elsevier, 1976:303–10.Google Scholar
  22. 22.
    De Wet B, Hollingshead J. Medicine compliance in paediatric outpatients. S Afr Med J 1980;58:846–8.Google Scholar
  23. 23.
    Foster GM. World Health Organization behavioral science research: problems and prospects. Soc Sci Med 1987;24:709–17.Google Scholar
  24. 24.
    Stolley PD, Becker MH, Lasagna L, McEvilla JD, Sloane LM. The relationship between physician characteristics and prescribing appropriateness. Med Care 1972;10:17–28.Google Scholar
  25. 25.
    Stanulovic M, Jakovljevic V, Roncevic N. Drug utilization in pediatrics: non medical factors affecting prescribers decision making. Eur J Clin Pharmacol 1984;27:237–41.Google Scholar
  26. 26.
    Güemes A. Farmacovigilancia intensiva en un servicio de urgencias hospitalario. [Intensive drug surveillance in an emergency unit] [dissertation]. La Laguna: Univ of La Laguna, 1986.Google Scholar
  27. 27.
    Moss FM, McNicol MW, McSwiggan DA, Miller DL. Survey of antibiotic prescribing in a district general hospital. I. Pattern of use. Lancet 1981;2:497–9.Google Scholar
  28. 28.
    Townsend TR, Shapiro M, Rosner B, Kass EH. Use of antimicrobial drugs in general hospitals. IV. Infants and children. Pediatrics 1979;64:573–8.Google Scholar
  29. 29.
    Gupta MP, Lee D, Smith R, Lee AA. Patrones de utilización de agentes antimicrobianos en la sala de pediatría del complejo hospitalario metropolitano de la Caja del Seguro Social [Drug utilization patterns of antibiotics in the paediatric board of the metropolitan hospital of the Social Security System in Panama]. Rev Med Caja Seg Soc 1983;15:327–32.Google Scholar
  30. 30.
    Chong Ho A, Lee D. Patrones de utilización de agentes antimicrobianos en la sala de pediatría del Hospital Manuel Amador Guerrero de Colón [Drug utilization patterns of antibiotics in the paediatric board of the Manuel Amador Guerrero Hospital of Colón]. Bol Soc Panamena Pediatria 1981;11:13–20.Google Scholar
  31. 31.
    Johansen KS. The time has come to reassess antibiotic usage [Report 06815]. Copenhagen: WHO Regional Office for Europe, 1987.Google Scholar
  32. 32.
    WHO. Drugs in the management of acute diarrhoea in infants and young children. Drug Inform 1985;(April–June):11–7.Google Scholar
  33. 33.
    Kreula E, Hemminki E. Frequency of psychotropic drug prescribing for children in Tampere, Finland. Acta Paediatr Scand 1978;67:449–52.Google Scholar
  34. 34.
    Massari B. La prescription de psychotropes en pschiatrie de l'enfant [Prescription of psychotropic drugs in child psychiatry]. Neuropsychiatr Enfance Adolesc 1984;32:433–41.Google Scholar
  35. 35.
    Quinn DM. Prevalence of psychoactive medication in children and adolescents [published erratum appears in Can J Psychiatry 1986;31(9):874]. Can J Psychiatry 1986;31(8):575–80.Google Scholar
  36. 36.
    Ray WA, Schaffner W, Federspiel CF. Differences between female and male children in the receipt of prescribed psychotropic and controlled-analgesic drugs. A five-year epidemiologic study. Med Care 1986;24:801–13.Google Scholar
  37. 37.
    Levin LS. Self-medication in Europe. A WHO-study. Swiss Pharma 1988;10:13–5.Google Scholar
  38. 38.
    Ridout S, Waters WE, George CF. Knowledge of and attitudes to medicines in the Southampton community. Br J Clin Pharmacol 1986;21:701–12.Google Scholar
  39. 39.
    Toverud EL, Andrew M. Drug use in children — parents' experiences and attitudes. In: Muller NF, Hekster YA, eds. Progress in clinical pharmacy. Rational use of drugs. Proceedings of the 28th European Symposium on Clinical Pharmacy; 1989 Oct 25–28; Nijmegen, the Netherlands. Noordwijk: European Society of Clinical Pharmacy, 1989.Google Scholar
  40. 40.
    McKenzie MW, Stewart RB, Weiss CF, Cluff LE. A pharmacist-based study of the epidemiology of adverse drug reactions in pediatric medicine patients. Am J Hosp Pharm 1973;30:898–903.Google Scholar
  41. 41.
    McKenzie MW, Marchall GL, Netxloff ML, Cluff LE. Adverse drug reactions leading to hospitalization in children. J Pediatrics 1976;89:487–90.Google Scholar
  42. 42.
    Kramer MS, Hutchinson TA, Flegel KM, Naimark L, Contardi R, Leduc DG. Adverse drug reactions in general pediatric outpatients. J Pediatrics 1985;106:305–10.Google Scholar
  43. 43.
    World Health Organization. Drugs in general practice. Report of a WHO Meeting, Schlangenbad, October 1982. EURO Report and Studies 91. Copenhagen: WHO Regional Office for Europe, 1985.Google Scholar
  44. 44.
    Cohen SN. Ethics of drug research in children. In: Pediatric pharmacology. Therapeutic principles in practice. Yaffe SJ, ed. New York: Grune & Stratton, 1980.Google Scholar
  45. 45.
    Radde IC, MacLeod SM. Therapeutic and nontherapeutic research in children. In: MacLeod SM, Radde IC, eds. Textbook of pediatric clinical pharmacology. Massachusetts: PSG Publishing Company, 1984.Google Scholar
  46. 46.
    Sonka LF. Drug development in pediatrics, problems and strategies. The point of view of the academic community. Pediatr Pharmacol 1980;1:21–4.Google Scholar
  47. 47.
    Wessling A. Continuous recording of drug prescribing in Sweden 1974–1983. Methods and examples of utilization of data. Eur J Clin Pharmacol 1987;33:7–13.Google Scholar
  48. 48.
    Boëthius G. Prescription of drugs 1970–75 in the county of Jämtland, Sweden. Epidemiological and clinical pharmacology aspects [dissertation]. Stockholm: Karolinska Institute, 1977.Google Scholar
  49. 49.
    Anonymous. Svensk Läkemedelsstatistik [Swedish drug statistics]. Stockholm: Apoteksbolaget, 1988.Google Scholar
  50. 50.
    Agenäs I, Jacobsson M, Kristofersson K. Diagnosreceptundersökningen [Diagnosis and therapy survey]. Svensk Farm Tidskr 1980;34:321.Google Scholar
  51. 51.
    Ray WA, Federspiel CF, Schaffner W. Prescribing of tetracycline to children less than 8 years old. A two-year epidemiologic study among ambulatory Tennessee medicaid recipients. JAMA 1977;237:2069–74.Google Scholar
  52. 52.
    Ray WA, Fink R, Schaffner W, Federspiel CF. Improving antibiotic prescribing in outpatient practice. Nonassociation of outcome with prescriber characteristics and measures of receptivity. Med Care 1985;23:1307–13.Google Scholar
  53. 53.
    Ray WA, Schaffner W, Federspiel CF. Persistence of improvement in antibiotic prescribing in office practice. JAMA 1985;253:1774–6.Google Scholar
  54. 54.
    Gruppo di studio sulla pressione arteriosia nell'anziano. Feasibility of a large prospective study in general practice: an Italian experience. Br Med J 1987;294:157–60.Google Scholar
  55. 55.
    Puche E, Saucedo R, García Morillas M, Bolaños J, Vila A. Estudio del botiquin familiar y algunas de sus características en la ciudad de Granada. Estudio realizado en 1548 familias [A study of 1548 family medicine cupboards, Granada, Spain]. Med Clin (Barcelona) 1982;79:118–21.Google Scholar
  56. 56.
    Fisher S, Bryant SG, Solovitz BL, Kluge RM. Patientinitiated postmarketing surveillance. A validation study. Clin Pharmacol 1987;27:843–54.Google Scholar
  57. 57.
    Lecuona M. Enfermedades y medicación del lactante en nuestro medio [Diseases and drugs in children being brest-fed] [dissertation]. La Laguna: Univ of La Laguna, 1988.Google Scholar
  58. 58.
    Hemminki E. Adverse reactions to antibiotic drugs: the present scope of the problem in outpatient care and possibilities for improvement. Int J Health Serv 1981;11:283–301.Google Scholar
  59. 59.
    Ives TJ, Frey JJ, Furr SJ, Bentz EJ. Effect of educational intervention on oral cephalosporin use in primary care. Arch Intern Med 1987;147:44–7.Google Scholar
  60. 60.
    Rylance G, ed. Drugs for children. Copenhagen: WHO. Regional Office for Europe, 1987.Google Scholar

Copyright information

© Royal Dutch Association for Advancement of Pharmacy 1992

Authors and Affiliations

  • Emilio J. Sanz
    • 1
  1. 1.Department of Pharmacology and PhysicalMedicine, University of La LagunaLa CuestaSpain

Personalised recommendations